Mr. Hylton Karon reports

IFABRIC CORP. LAUNCHES FRONTLINE CLINICALLY VALIDATED ANTIMICROBIAL SCRUBS AT MAJOR CANADIAN WHOLESALE CLUB RETAILER

iFabric Corp.'s wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. (IFTNA), has launched Frontline, a new medical apparel (scrubs) brand engineered and manufactured by IFTNA, for sale at a major Canadian wholesale club retailer.

The company believes this launch represents a significant commercial milestone in bringing clinically proven infection prevention textile technology to a broader market of health care professionals while establishing IFTNA's expanding role as a full-scope partner delivering proprietary technologies from chemistry development through finished consumer products distributed at major retailer scale.

Frontline scrubs incorporate IFTNA's PROTX2 anti-microbial technology together with ecoPEL fluorine-free durable water repellent technology, the same combination of technologies validated in IFTNA's clinical trial, the results of which were peer reviewed and published last year in the Journal of Hospital Infection. This trial demonstrated statistically significant reductions in surface bacterial contamination on treated scrubs worn in real-world health care environments compared with untreated scrubs.

"Frontline scrubs translate peer-reviewed clinical evidence into accessible, everyday apparel built for the realities of modern health care -- long shifts, frequent laundering, and regular exposure to bacteria from fluids and surfaces," said Giancarlo Beevis, president and chief executive officer of IFTNA. "By combining PROTX2 anti-microbial protection with ecoPEL water-repellent durability and sustainable chemistry, we're delivering clinically validated performance through one of North America's most trusted, value-focused retail platforms."

The Frontline products are now available on-line.

Expanding market access for clinically validated anti-microbial technology

The company developed Frontline to bring the clinically supported performance benefits of PROTX2- and ecoPEL-treated scrubs to a broader population of health care professionals and make it accessible through a highly scalable retail channel.

"Health care professionals have increasingly demanded anti-microbial solutions supported by rigorous clinical data rather than marketing claims alone," continued Mr. Beevis. "The peer-reviewed validation of our technology platform, combined with adoption by major retail partners, positions IFTNA to address what we believe is a substantial and growing demand for clinically proven infection control apparel in health care settings."

The Frontline assortment is launching initially on the wholesaler's national e-commerce platform. Subject to member adoption, retailer planning and other commercial considerations, the company believes the program has the potential to expand to additional product assortments and, in time, to brick-and-mortar locations.

This launch marks the second major retail adoption of IFTNA's performance apparel technologies in a program where IFTNA serves as the end-to-end partner across branding, product design, development and manufacturing. The company views this as an important validation of IFTNA's ability to deliver full-scope programs at scale, moving from lab-engineered chemistries and textile finishing to product design and manufacturing of consumer-ready products.

Further, this launch provides validation of IFTNA's ability to commercialize its proprietary anti-microbial and sustainability-focused technology platforms at retail scale. With heightened awareness of the need for infection prevention and the growing health care sector demand for clinically validated solutions, the company believes IFTNA's proprietary technology position and demonstrated ability to deliver full-scope programs creates significant opportunities for continued category expansion and market penetration in both the medical and performance apparel segments.

About iFabric Corp.

iFabric develops, licenses and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced fabric functionality -- ranging from anti-microbial technologies to PFAS-free (perfluoroalkyl and polyfluoroalkyl substances) water repellency -- across multiple end uses.

About Intelligent Fabric Technologies (North America) Inc. (IFTNA)

IFTNA, a wholly owned subsidiary of iFabric, engineers and supplies proprietary textile chemistries and provides end-to-end program capabilities spanning technology integration, product development, branding support and manufacturing execution across consumer, medical and industrial markets.

About PROTX2

PROTX2 is an eco-friendly textile technology designed to provide anti-microbial and anti-odour protection. When applied, PROTX2 is engineered to deliver durable performance intended to last through the life of the garment.

About ecoPEL

ecoPEL is a fluorine-free durable water repellent (DWR) technology designed to help deliver water repellency while maintaining fabric comfort and breathability and to support sustainability objectives by avoiding fluorinated chemistry.

We seek Safe Harbor.